 This trial will evaluate the feasibility of translating preclinical Chemical Exchange Saturation Transfer CEST MRI protocol designed to estimate tumor extracellular pH pHe, to a clinical MRI scanner in women with early stage breast cancer. This trial will generate preliminary data regarding the feasibility of this imaging technique. If successful, in future studies CEST MRI may serve as an imaging biomarker for acidosis and hypoxia. 